GREY:ATBPF - Post by User
Comment by
MrMugsyon Jun 18, 2021 9:39am
319 Views
Post# 33410493
RE:RJ Initates Coverage... G&M
RE:RJ Initates Coverage... G&Mace1mccoy wrote: * Raymond James analyst David Novak initiated coverage of Antibe Therapeutics Inc. (ATE-T) with an “outperform” rating and $7 target. The current average is $17.59.
“We believe ATE shares are well-positioned for a significant market re-rating over the next 12-months and thus view the company as an attractive investment opportunity for risk-tolerant investors,” he said.
And the Raymond James conference call is next Tuesday !!!